摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

acenaphthen-5-ylmethyl-methylamine | 36218-58-3

中文名称
——
中文别名
——
英文名称
acenaphthen-5-ylmethyl-methylamine
英文别名
(1,2-dihydroacenaphthylen-5-yl)-N-methylmethanamine;1-(1,2-Dihydroacenaphthylen-5-yl)-N-methylmethanamine
acenaphthen-5-ylmethyl-methylamine化学式
CAS
36218-58-3
化学式
C14H15N
mdl
——
分子量
197.28
InChiKey
REYHSZCSIPLEHP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • Compositions comprising multiple bioactive agents, and methods of using the same
    申请人:Berman M. Judd
    公开号:US20060142265A1
    公开(公告)日:2006-06-29
    In part, the present invention is directed to compositions comprising a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions comprising a compound of formulas I-III and at least one other antibacterial agent.
    本发明的一部分涉及含有FabI抑制剂和至少一种其他生物活性剂的组合物。另一部分,本发明涉及含有I-III式化合物和至少一种其他抗菌剂的抗菌组合物。
  • Heterocyclic compounds, methods of making them and their use in therapy
    申请人:Berman Judd
    公开号:US20060183908A1
    公开(公告)日:2006-08-17
    In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R 2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.
    部分地,本发明涉及公式(I)中的抗菌化合物,其中A是双环杂芳基环或三环环,并且R2是杂环残基; L是键合或L是烷基,烯基或环烷基。
  • Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy
    申请人:Berman Judd
    公开号:US20110124633A1
    公开(公告)日:2011-05-26
    In part, the present invention is directed to antibacterial compounds.
    部分地,本发明涉及抗菌化合物。
  • Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same
    申请人:BERMAN JUDD M.
    公开号:US20120010127A1
    公开(公告)日:2012-01-12
    In part, the present invention is directed to compositions comprising a FabI inhibitor and at least one other bioactive agent. In another part, the present invention is directed to antibacterial compositions comprising a compound of formulas I-III and at least one other antibacterial agent.
    本发明的一部分涉及包含FabI抑制剂和至少一种其他生物活性剂的组合物。另一部分涉及包含I-III式化合物和至少一种其他抗菌剂的抗菌组合物。
  • 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
    申请人:Pauls Henry
    公开号:US20090156578A1
    公开(公告)日:2009-06-18
    In part, the present invention is directed towards compounds with FabI inhibiting properties. Such compounds may also inhibit other enzymes, including those similar to FabI either structurally or functionally, for example, Fab K. Kits and compositions that include the disclosed compounds are also provided. Methods of treating a subject with a bacterial illness is also disclosed.
    本发明的部分涉及具有FabI抑制性质的化合物。这些化合物也可能抑制其他酶,包括那些在结构或功能上类似于FabI的酶,例如Fab K。还提供了包括所述化合物的试剂盒和组合物。还揭示了治疗细菌性疾病患者的方法。
查看更多